261 related articles for article (PubMed ID: 15264863)
21. Binding and internalization of anti-sarcoma IgG and IgM antibodies.
Chao TC; Walter RJ; Greager JA
J Surg Res; 1997 Jun; 70(1):27-33. PubMed ID: 9228923
[TBL] [Abstract][Full Text] [Related]
22. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
[TBL] [Abstract][Full Text] [Related]
23. Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.
Mohamed Amar IA; Huvelle S; Douez E; Letast S; Henrion S; Viaud-Massuard MC; Aubrey N; Allard-Vannier E; Joubert N; Denevault-Sabourin C
Eur J Med Chem; 2022 Feb; 229():114063. PubMed ID: 34974337
[TBL] [Abstract][Full Text] [Related]
24. E-selectin up-regulation allows for targeted drug delivery in prostate cancer.
Bhaskar V; Law DA; Ibsen E; Breinberg D; Cass KM; DuBridge RB; Evangelista F; Henshall SM; Hevezi P; Miller JC; Pong M; Powers R; Senter P; Stockett D; Sutherland RL; von Freeden-Jeffry U; Willhite D; Murray R; Afar DE; Ramakrishnan V
Cancer Res; 2003 Oct; 63(19):6387-94. PubMed ID: 14559828
[TBL] [Abstract][Full Text] [Related]
25. Dipeptide-based highly potent doxorubicin antibody conjugates.
Jeffrey SC; Nguyen MT; Andreyka JB; Meyer DL; Doronina SO; Senter PD
Bioorg Med Chem Lett; 2006 Jan; 16(2):358-62. PubMed ID: 16275070
[TBL] [Abstract][Full Text] [Related]
26. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Tse KF; Jeffers M; Pollack VA; McCabe DA; Shadish ML; Khramtsov NV; Hackett CS; Shenoy SG; Kuang B; Boldog FL; MacDougall JR; Rastelli L; Herrmann J; Gallo M; Gazit-Bornstein G; Senter PD; Meyer DL; Lichenstein HS; LaRochelle WJ
Clin Cancer Res; 2006 Feb; 12(4):1373-82. PubMed ID: 16489096
[TBL] [Abstract][Full Text] [Related]
27. Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro.
Dürrbach A; Angevin E; Poncet P; Rouleau M; Chavanel G; Chapel A; Thierry D; Gorter A; Hirsch R; Charpentier B; Senik A; Hirsch F
Cancer Gene Ther; 1999; 6(6):564-71. PubMed ID: 10608353
[TBL] [Abstract][Full Text] [Related]
28. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
29. Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates.
Austin CD; Wen X; Gazzard L; Nelson C; Scheller RH; Scales SJ
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):17987-92. PubMed ID: 16322102
[TBL] [Abstract][Full Text] [Related]
30. Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.
Burke PJ; Toki BE; Meyer DW; Miyamoto JB; Kissler KM; Anderson M; Senter PD; Jeffrey SC
Bioorg Med Chem Lett; 2009 May; 19(10):2650-3. PubMed ID: 19386499
[TBL] [Abstract][Full Text] [Related]
31. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG
Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337
[TBL] [Abstract][Full Text] [Related]
33. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
[TBL] [Abstract][Full Text] [Related]
34. Efficient immobilization of a ligand antibody with high antigen-binding activity by use of a polystyrene-binding peptide and an intelligent microtiter plate.
Kumada Y; Hamasaki K; Shiritani Y; Ohse T; Kishimoto M
J Biotechnol; 2009 Jun; 142(2):135-41. PubMed ID: 19501265
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
36. Contribution of linker stability to the activities of anticancer immunoconjugates.
Alley SC; Benjamin DR; Jeffrey SC; Okeley NM; Meyer DL; Sanderson RJ; Senter PD
Bioconjug Chem; 2008 Mar; 19(3):759-65. PubMed ID: 18314937
[TBL] [Abstract][Full Text] [Related]
37. Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA.
Stanker LH; Merrill P; Scotcher MC; Cheng LW
J Immunol Methods; 2008 Jul; 336(1):1-8. PubMed ID: 18452945
[TBL] [Abstract][Full Text] [Related]
38. Constitutive internalization of murine MHC class I molecules.
Mahmutefendić H; Blagojević G; Kucić N; Lucin P
J Cell Physiol; 2007 Feb; 210(2):445-55. PubMed ID: 17044074
[TBL] [Abstract][Full Text] [Related]
39. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer.
Afar DE; Bhaskar V; Ibsen E; Breinberg D; Henshall SM; Kench JG; Drobnjak M; Powers R; Wong M; Evangelista F; O'Hara C; Powers D; DuBridge RB; Caras I; Winter R; Anderson T; Solvason N; Stricker PD; Cordon-Cardo C; Scher HI; Grygiel JJ; Sutherland RL; Murray R; Ramakrishnan V; Law DA
Mol Cancer Ther; 2004 Aug; 3(8):921-32. PubMed ID: 15299075
[TBL] [Abstract][Full Text] [Related]
40. Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.
Valliere-Douglass JF; McFee WA; Salas-Solano O
Anal Chem; 2012 Mar; 84(6):2843-9. PubMed ID: 22384990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
